Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32614Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Gan, Hui K | - |
| dc.date | 2023 | - |
| dc.date.accessioned | 2023-04-14T02:47:11Z | - |
| dc.date.available | 2023-04-14T02:47:11Z | - |
| dc.date.issued | 2023-04 | - |
| dc.identifier.citation | Neuro-Oncology Practice 2023; 10(2): 111-112 | en_US |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32614 | - |
| dc.language.iso | eng | - |
| dc.title | MGMT methylation: Is it time to embrace the shades of grey? | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.journaltitle | Neuro-Oncology Practice | en_US |
| dc.identifier.affiliation | La Trobe University School of Cancer Medicine, Victoria, Australia | en_US |
| dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en_US |
| dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
| dc.identifier.affiliation | Australian Brain Cancer Research Alliance, Melbourne, Australia. | en_US |
| dc.identifier.doi | 10.1093/nop/npad003 | en_US |
| dc.type.content | Text | en_US |
| dc.identifier.orcid | 0000-0001-7319-8546 | en_US |
| dc.identifier.pubmedid | 36970166 | - |
| dc.description.volume | 10 | - |
| dc.description.issue | 2 | - |
| dc.description.startpage | 111 | - |
| dc.description.endpage | 112 | - |
| local.name.researcher | Gan, Hui K | |
| item.languageiso639-1 | en | - |
| item.fulltext | No Fulltext | - |
| item.cerifentitytype | Publications | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.openairetype | Journal Article | - |
| item.grantfulltext | none | - |
| crisitem.author.dept | Medical Oncology | - |
| crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.